CN115178105A - Long-acting filtering membrane with uniformly distributed biological electrets on polylactic acid nanofiber surface and preparation method thereof - Google Patents
Long-acting filtering membrane with uniformly distributed biological electrets on polylactic acid nanofiber surface and preparation method thereof Download PDFInfo
- Publication number
- CN115178105A CN115178105A CN202211024261.8A CN202211024261A CN115178105A CN 115178105 A CN115178105 A CN 115178105A CN 202211024261 A CN202211024261 A CN 202211024261A CN 115178105 A CN115178105 A CN 115178105A
- Authority
- CN
- China
- Prior art keywords
- polylactic acid
- biological
- hydroxyapatite
- electret
- preparation
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 229920000747 poly(lactic acid) Polymers 0.000 title claims abstract description 81
- 239000004626 polylactic acid Substances 0.000 title claims abstract description 81
- 239000002121 nanofiber Substances 0.000 title claims abstract description 72
- 239000012528 membrane Substances 0.000 title claims abstract description 62
- 238000002360 preparation method Methods 0.000 title claims abstract description 38
- 238000001914 filtration Methods 0.000 title claims abstract description 32
- 229910052588 hydroxylapatite Inorganic materials 0.000 claims abstract description 58
- XYJRXVWERLGGKC-UHFFFAOYSA-D pentacalcium;hydroxide;triphosphate Chemical compound [OH-].[Ca+2].[Ca+2].[Ca+2].[Ca+2].[Ca+2].[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O XYJRXVWERLGGKC-UHFFFAOYSA-D 0.000 claims abstract description 57
- 239000000835 fiber Substances 0.000 claims abstract description 33
- 238000001523 electrospinning Methods 0.000 claims abstract description 18
- 230000007774 longterm Effects 0.000 claims abstract description 11
- 238000000034 method Methods 0.000 claims abstract description 10
- 230000003592 biomimetic effect Effects 0.000 claims abstract description 8
- 230000033558 biomineral tissue development Effects 0.000 claims abstract description 8
- 238000009832 plasma treatment Methods 0.000 claims abstract description 7
- 230000008569 process Effects 0.000 claims abstract description 3
- 239000006185 dispersion Substances 0.000 claims description 29
- ZMXDDKWLCZADIW-UHFFFAOYSA-N N,N-Dimethylformamide Chemical compound CN(C)C=O ZMXDDKWLCZADIW-UHFFFAOYSA-N 0.000 claims description 21
- YMWUJEATGCHHMB-UHFFFAOYSA-N Dichloromethane Chemical group ClCCl YMWUJEATGCHHMB-UHFFFAOYSA-N 0.000 claims description 15
- 239000007864 aqueous solution Substances 0.000 claims description 15
- 238000006243 chemical reaction Methods 0.000 claims description 15
- 238000005516 engineering process Methods 0.000 claims description 15
- XKRFYHLGVUSROY-UHFFFAOYSA-N Argon Chemical compound [Ar] XKRFYHLGVUSROY-UHFFFAOYSA-N 0.000 claims description 14
- 238000009827 uniform distribution Methods 0.000 claims description 13
- 238000009987 spinning Methods 0.000 claims description 12
- 238000003756 stirring Methods 0.000 claims description 10
- 239000007789 gas Substances 0.000 claims description 9
- 239000003795 chemical substances by application Substances 0.000 claims description 8
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 8
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 claims description 7
- HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 claims description 7
- 229910052786 argon Inorganic materials 0.000 claims description 7
- 238000000889 atomisation Methods 0.000 claims description 7
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 6
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 claims description 6
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 claims description 6
- 230000004888 barrier function Effects 0.000 claims description 6
- ZCCIPPOKBCJFDN-UHFFFAOYSA-N calcium nitrate Chemical compound [Ca+2].[O-][N+]([O-])=O.[O-][N+]([O-])=O ZCCIPPOKBCJFDN-UHFFFAOYSA-N 0.000 claims description 6
- 159000000007 calcium salts Chemical class 0.000 claims description 6
- NBIIXXVUZAFLBC-UHFFFAOYSA-K phosphate Chemical compound [O-]P([O-])([O-])=O NBIIXXVUZAFLBC-UHFFFAOYSA-K 0.000 claims description 6
- 239000000243 solution Substances 0.000 claims description 6
- BYEAHWXPCBROCE-UHFFFAOYSA-N 1,1,1,3,3,3-hexafluoropropan-2-ol Chemical compound FC(F)(F)C(O)C(F)(F)F BYEAHWXPCBROCE-UHFFFAOYSA-N 0.000 claims description 5
- SECXISVLQFMRJM-UHFFFAOYSA-N N-Methylpyrrolidone Chemical compound CN1CCCC1=O SECXISVLQFMRJM-UHFFFAOYSA-N 0.000 claims description 5
- KFZMGEQAYNKOFK-UHFFFAOYSA-N Isopropanol Chemical compound CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 claims description 4
- 229910019142 PO4 Inorganic materials 0.000 claims description 4
- LFVGISIMTYGQHF-UHFFFAOYSA-N ammonium dihydrogen phosphate Chemical group [NH4+].OP(O)([O-])=O LFVGISIMTYGQHF-UHFFFAOYSA-N 0.000 claims description 4
- 229910000387 ammonium dihydrogen phosphate Inorganic materials 0.000 claims description 4
- VSGNNIFQASZAOI-UHFFFAOYSA-L calcium acetate Chemical compound [Ca+2].CC([O-])=O.CC([O-])=O VSGNNIFQASZAOI-UHFFFAOYSA-L 0.000 claims description 4
- 239000001639 calcium acetate Substances 0.000 claims description 4
- 229960005147 calcium acetate Drugs 0.000 claims description 4
- 235000011092 calcium acetate Nutrition 0.000 claims description 4
- 235000019837 monoammonium phosphate Nutrition 0.000 claims description 4
- 239000003960 organic solvent Substances 0.000 claims description 4
- 239000010452 phosphate Substances 0.000 claims description 4
- WRIDQFICGBMAFQ-UHFFFAOYSA-N (E)-8-Octadecenoic acid Natural products CCCCCCCCCC=CCCCCCCC(O)=O WRIDQFICGBMAFQ-UHFFFAOYSA-N 0.000 claims description 3
- LQJBNNIYVWPHFW-UHFFFAOYSA-N 20:1omega9c fatty acid Natural products CCCCCCCCCCC=CCCCCCCCC(O)=O LQJBNNIYVWPHFW-UHFFFAOYSA-N 0.000 claims description 3
- QSBYPNXLFMSGKH-UHFFFAOYSA-N 9-Heptadecensaeure Natural products CCCCCCCC=CCCCCCCCC(O)=O QSBYPNXLFMSGKH-UHFFFAOYSA-N 0.000 claims description 3
- UXVMQQNJUSDDNG-UHFFFAOYSA-L Calcium chloride Chemical group [Cl-].[Cl-].[Ca+2] UXVMQQNJUSDDNG-UHFFFAOYSA-L 0.000 claims description 3
- ZKQDCIXGCQPQNV-UHFFFAOYSA-N Calcium hypochlorite Chemical compound [Ca+2].Cl[O-].Cl[O-] ZKQDCIXGCQPQNV-UHFFFAOYSA-N 0.000 claims description 3
- LZZYPRNAOMGNLH-UHFFFAOYSA-M Cetrimonium bromide Chemical group [Br-].CCCCCCCCCCCCCCCC[N+](C)(C)C LZZYPRNAOMGNLH-UHFFFAOYSA-M 0.000 claims description 3
- ZQPPMHVWECSIRJ-UHFFFAOYSA-N Oleic acid Natural products CCCCCCCCC=CCCCCCCCC(O)=O ZQPPMHVWECSIRJ-UHFFFAOYSA-N 0.000 claims description 3
- 239000005642 Oleic acid Substances 0.000 claims description 3
- 235000021355 Stearic acid Nutrition 0.000 claims description 3
- 229910052586 apatite Inorganic materials 0.000 claims description 3
- 239000001110 calcium chloride Substances 0.000 claims description 3
- 229910001628 calcium chloride Inorganic materials 0.000 claims description 3
- MNNHAPBLZZVQHP-UHFFFAOYSA-N diammonium hydrogen phosphate Chemical compound [NH4+].[NH4+].OP([O-])([O-])=O MNNHAPBLZZVQHP-UHFFFAOYSA-N 0.000 claims description 3
- BNIILDVGGAEEIG-UHFFFAOYSA-L disodium hydrogen phosphate Chemical compound [Na+].[Na+].OP([O-])([O-])=O BNIILDVGGAEEIG-UHFFFAOYSA-L 0.000 claims description 3
- GVGUFUZHNYFZLC-UHFFFAOYSA-N dodecyl benzenesulfonate;sodium Chemical compound [Na].CCCCCCCCCCCCOS(=O)(=O)C1=CC=CC=C1 GVGUFUZHNYFZLC-UHFFFAOYSA-N 0.000 claims description 3
- 239000001307 helium Substances 0.000 claims description 3
- 229910052734 helium Inorganic materials 0.000 claims description 3
- SWQJXJOGLNCZEY-UHFFFAOYSA-N helium atom Chemical compound [He] SWQJXJOGLNCZEY-UHFFFAOYSA-N 0.000 claims description 3
- 125000002887 hydroxy group Chemical group [H]O* 0.000 claims description 3
- QXJSBBXBKPUZAA-UHFFFAOYSA-N isooleic acid Natural products CCCCCCCC=CCCCCCCCCC(O)=O QXJSBBXBKPUZAA-UHFFFAOYSA-N 0.000 claims description 3
- 229910000402 monopotassium phosphate Inorganic materials 0.000 claims description 3
- 235000019796 monopotassium phosphate Nutrition 0.000 claims description 3
- QIQXTHQIDYTFRH-UHFFFAOYSA-N octadecanoic acid Chemical compound CCCCCCCCCCCCCCCCCC(O)=O QIQXTHQIDYTFRH-UHFFFAOYSA-N 0.000 claims description 3
- OQCDKBAXFALNLD-UHFFFAOYSA-N octadecanoic acid Natural products CCCCCCCC(C)CCCCCCCCC(O)=O OQCDKBAXFALNLD-UHFFFAOYSA-N 0.000 claims description 3
- ZQPPMHVWECSIRJ-KTKRTIGZSA-N oleic acid Chemical compound CCCCCCCC\C=C/CCCCCCCC(O)=O ZQPPMHVWECSIRJ-KTKRTIGZSA-N 0.000 claims description 3
- VSIIXMUUUJUKCM-UHFFFAOYSA-D pentacalcium;fluoride;triphosphate Chemical compound [F-].[Ca+2].[Ca+2].[Ca+2].[Ca+2].[Ca+2].[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O VSIIXMUUUJUKCM-UHFFFAOYSA-D 0.000 claims description 3
- PJNZPQUBCPKICU-UHFFFAOYSA-N phosphoric acid;potassium Chemical compound [K].OP(O)(O)=O PJNZPQUBCPKICU-UHFFFAOYSA-N 0.000 claims description 3
- 229940080264 sodium dodecylbenzenesulfonate Drugs 0.000 claims description 3
- 239000008117 stearic acid Substances 0.000 claims description 3
- BHPQYMZQTOCNFJ-UHFFFAOYSA-N Calcium cation Chemical compound [Ca+2] BHPQYMZQTOCNFJ-UHFFFAOYSA-N 0.000 claims description 2
- DBMJMQXJHONAFJ-UHFFFAOYSA-M Sodium laurylsulphate Chemical compound [Na+].CCCCCCCCCCCCOS([O-])(=O)=O DBMJMQXJHONAFJ-UHFFFAOYSA-M 0.000 claims description 2
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 claims description 2
- 229910001424 calcium ion Inorganic materials 0.000 claims description 2
- 238000001816 cooling Methods 0.000 claims description 2
- ZPWVASYFFYYZEW-UHFFFAOYSA-L dipotassium hydrogen phosphate Chemical compound [K+].[K+].OP([O-])([O-])=O ZPWVASYFFYYZEW-UHFFFAOYSA-L 0.000 claims description 2
- 239000001257 hydrogen Substances 0.000 claims description 2
- 229910052739 hydrogen Inorganic materials 0.000 claims description 2
- 125000004435 hydrogen atom Chemical class [H]* 0.000 claims description 2
- 239000007788 liquid Substances 0.000 claims description 2
- 238000007144 microwave assisted synthesis reaction Methods 0.000 claims description 2
- 239000011259 mixed solution Substances 0.000 claims description 2
- 229910052757 nitrogen Inorganic materials 0.000 claims description 2
- 239000001301 oxygen Substances 0.000 claims description 2
- 229910052760 oxygen Inorganic materials 0.000 claims description 2
- 229940085991 phosphate ion Drugs 0.000 claims description 2
- 229940051841 polyoxyethylene ether Drugs 0.000 claims description 2
- 229920000056 polyoxyethylene ether Polymers 0.000 claims description 2
- 230000035484 reaction time Effects 0.000 claims description 2
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 claims 1
- NBIIXXVUZAFLBC-UHFFFAOYSA-M dihydrogenphosphate Chemical compound OP(O)([O-])=O NBIIXXVUZAFLBC-UHFFFAOYSA-M 0.000 claims 1
- -1 octyl phenyl Chemical group 0.000 claims 1
- 239000011734 sodium Substances 0.000 claims 1
- 229910052708 sodium Inorganic materials 0.000 claims 1
- 239000000463 material Substances 0.000 abstract description 15
- 238000005054 agglomeration Methods 0.000 abstract description 5
- 230000002776 aggregation Effects 0.000 abstract description 4
- 230000004913 activation Effects 0.000 abstract description 2
- 239000003595 mist Substances 0.000 abstract 1
- 238000000465 moulding Methods 0.000 abstract 1
- 230000001360 synchronised effect Effects 0.000 abstract 1
- 238000012360 testing method Methods 0.000 description 14
- 230000000052 comparative effect Effects 0.000 description 10
- 230000000694 effects Effects 0.000 description 10
- 239000000203 mixture Substances 0.000 description 6
- 239000011550 stock solution Substances 0.000 description 6
- 239000002245 particle Substances 0.000 description 5
- 230000005540 biological transmission Effects 0.000 description 3
- 229960001701 chloroform Drugs 0.000 description 3
- 229910001873 dinitrogen Inorganic materials 0.000 description 3
- 239000002105 nanoparticle Substances 0.000 description 3
- 239000002861 polymer material Substances 0.000 description 3
- NBIIXXVUZAFLBC-UHFFFAOYSA-N Phosphoric acid Chemical group OP(O)(O)=O NBIIXXVUZAFLBC-UHFFFAOYSA-N 0.000 description 2
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 2
- 230000008901 benefit Effects 0.000 description 2
- 210000000988 bone and bone Anatomy 0.000 description 2
- 230000008021 deposition Effects 0.000 description 2
- 238000009826 distribution Methods 0.000 description 2
- QORWJWZARLRLPR-UHFFFAOYSA-H tricalcium bis(phosphate) Chemical compound [Ca+2].[Ca+2].[Ca+2].[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O QORWJWZARLRLPR-UHFFFAOYSA-H 0.000 description 2
- 241001465754 Metazoa Species 0.000 description 1
- VVQNEPGJFQJSBK-UHFFFAOYSA-N Methyl methacrylate Chemical compound COC(=O)C(C)=C VVQNEPGJFQJSBK-UHFFFAOYSA-N 0.000 description 1
- 229920005372 Plexiglas® Polymers 0.000 description 1
- 239000000443 aerosol Substances 0.000 description 1
- 238000003915 air pollution Methods 0.000 description 1
- 229910000147 aluminium phosphate Inorganic materials 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 230000015556 catabolic process Effects 0.000 description 1
- 238000012512 characterization method Methods 0.000 description 1
- 239000002131 composite material Substances 0.000 description 1
- 239000013078 crystal Substances 0.000 description 1
- 229920006237 degradable polymer Polymers 0.000 description 1
- 238000006731 degradation reaction Methods 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 230000018109 developmental process Effects 0.000 description 1
- 238000009792 diffusion process Methods 0.000 description 1
- 230000007613 environmental effect Effects 0.000 description 1
- 239000000945 filler Substances 0.000 description 1
- 230000005484 gravity Effects 0.000 description 1
- 230000036541 health Effects 0.000 description 1
- 238000009776 industrial production Methods 0.000 description 1
- 150000002500 ions Chemical class 0.000 description 1
- 230000005923 long-lasting effect Effects 0.000 description 1
- 239000008204 material by function Substances 0.000 description 1
- 230000004060 metabolic process Effects 0.000 description 1
- 229910000403 monosodium phosphate Inorganic materials 0.000 description 1
- 235000019799 monosodium phosphate Nutrition 0.000 description 1
- 235000021313 oleic acid Nutrition 0.000 description 1
- 238000011056 performance test Methods 0.000 description 1
- 229920003023 plastic Polymers 0.000 description 1
- 239000004033 plastic Substances 0.000 description 1
- 210000004508 polar body Anatomy 0.000 description 1
- 230000010287 polarization Effects 0.000 description 1
- 229920000642 polymer Polymers 0.000 description 1
- 238000012545 processing Methods 0.000 description 1
- 102000004169 proteins and genes Human genes 0.000 description 1
- 108090000623 proteins and genes Proteins 0.000 description 1
- 238000004062 sedimentation Methods 0.000 description 1
- 238000007873 sieving Methods 0.000 description 1
- 229910052710 silicon Inorganic materials 0.000 description 1
- 239000010703 silicon Substances 0.000 description 1
- 239000011780 sodium chloride Substances 0.000 description 1
- AJPJDKMHJJGVTQ-UHFFFAOYSA-M sodium dihydrogen phosphate Chemical compound [Na+].OP(O)([O-])=O AJPJDKMHJJGVTQ-UHFFFAOYSA-M 0.000 description 1
- 235000019333 sodium laurylsulphate Nutrition 0.000 description 1
- 239000007787 solid Substances 0.000 description 1
- 238000001179 sorption measurement Methods 0.000 description 1
- 238000003860 storage Methods 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 230000002194 synthesizing effect Effects 0.000 description 1
- 238000009864 tensile test Methods 0.000 description 1
- 210000001519 tissue Anatomy 0.000 description 1
- 229940070527 tourmaline Drugs 0.000 description 1
- 229910052613 tourmaline Inorganic materials 0.000 description 1
- 239000011032 tourmaline Substances 0.000 description 1
Images
Classifications
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01D—SEPARATION
- B01D71/00—Semi-permeable membranes for separation processes or apparatus characterised by the material; Manufacturing processes specially adapted therefor
- B01D71/06—Organic material
- B01D71/48—Polyesters
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01D—SEPARATION
- B01D67/00—Processes specially adapted for manufacturing semi-permeable membranes for separation processes or apparatus
- B01D67/0079—Manufacture of membranes comprising organic and inorganic components
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01D—SEPARATION
- B01D69/00—Semi-permeable membranes for separation processes or apparatus characterised by their form, structure or properties; Manufacturing processes specially adapted therefor
- B01D69/02—Semi-permeable membranes for separation processes or apparatus characterised by their form, structure or properties; Manufacturing processes specially adapted therefor characterised by their properties
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01D—SEPARATION
- B01D2323/00—Details relating to membrane preparation
- B01D2323/39—Electrospinning
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01D—SEPARATION
- B01D2325/00—Details relating to properties of membranes
- B01D2325/26—Electrical properties
Landscapes
- Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Inorganic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Manufacturing & Machinery (AREA)
- Artificial Filaments (AREA)
- Nonwoven Fabrics (AREA)
Abstract
本发明公开了一种生物驻极体在聚乳酸纳米纤维表面均分布的长效过滤膜及其制备方法,高效合成生物驻极体材料并将其均匀分布在聚乳酸纳米纤维表面,进而全面提高力学性能、表面电位和空气过滤效率的技术方案,所述生物驻极体材料为微波辅助仿生矿化合成的羟基磷灰石纳米晶须,通过等离子体处理获得表面活化和高分散性,然后雾化、沉积到同步静电纺丝的聚乳酸纳米纤维表面,最终获得高表面电位、高力学性能、高过滤效率、长效过滤的全降解纳米纤维膜。该方法能良好控制生物驻极体的微观结构,抑制了纳米级驻极体自身团聚或在成型过程中局部团聚,从而在保证静电纺丝聚乳酸纤维膜良好加工性的同时,提高纤维膜的表面电位、过滤性能和力学性能。
The invention discloses a long-acting filter membrane in which biological electrets are evenly distributed on the surface of polylactic acid nanofibers and a preparation method thereof. The biological electret material is efficiently synthesized and evenly distributed on the surface of polylactic acid nanofibers, thereby comprehensively improving the The technical scheme of mechanical properties, surface potential and air filtration efficiency, the biological electret material is hydroxyapatite nanowhisker synthesized by microwave-assisted biomimetic mineralization, surface activation and high dispersibility are obtained by plasma treatment, and then mist It is synthesized and deposited on the surface of synchronous electrospinning polylactic acid nanofibers, and finally a fully degradable nanofiber membrane with high surface potential, high mechanical properties, high filtration efficiency and long-term filtration is obtained. The method can well control the microstructure of the biological electret, inhibit the self-agglomeration of the nano-scale electret or local agglomeration during the molding process, so as to ensure the good processability of the electrospinning polylactic acid fiber film and improve the fiber film's performance. Surface potential, filtration properties and mechanical properties.
Description
技术领域technical field
本发明涉及功能材料技术领域,具体涉及一种生物驻极体在聚乳酸纳米纤维表面均分布的长效过滤膜及其制备方法。The invention relates to the technical field of functional materials, in particular to a long-acting filter membrane in which biological electrets are evenly distributed on the surface of polylactic acid nanofibers and a preparation method thereof.
背景技术Background technique
空气污染是一个长期的全球性问题,危害大气环境和人类健康,而空气过滤是提高空气质量的一个关键和有效的方法。基于纳米纤维的过滤介质具有直径小、比表面积高和孔隙率高等优点,主要通过物理筛分提高了过滤的耐久性,已广泛应用于空气过滤领域。目前生产纳米纤维最典型的技术之一是静电纺丝,且已实现了大规模的工业化生产。然而,传统静电纺丝高分子材料在自然界中难以降解,对环境保护提出了巨大的挑战。聚乳酸作为一种新型生物基可降解材料,具有高力学性能、良好生物相容性和生物降解性等优异性能,在空气过滤材料领域展现出替代传统高分子材料的良好应用前景。Air pollution is a long-term global problem that endangers the atmospheric environment and human health, and air filtration is a key and effective way to improve air quality. Nanofiber-based filtration media have the advantages of small diameter, high specific surface area, and high porosity, which improve the durability of filtration mainly through physical sieving, and have been widely used in the field of air filtration. One of the most typical technologies for producing nanofibers is electrospinning, and large-scale industrial production has been achieved. However, traditional electrospun polymer materials are difficult to degrade in nature, posing a huge challenge to environmental protection. As a new bio-based degradable material, polylactic acid has excellent properties such as high mechanical properties, good biocompatibility and biodegradability, and has shown a good application prospect in the field of air filter materials to replace traditional polymer materials.
普通的纤维过滤材料主要依靠布朗扩散、截留、惯性碰撞、重力沉降等机械拦截作用来过滤空气中的颗粒,但对亚微米级颗粒的过滤效果并不理想。因而,常在纤维中需加入驻极体,不仅提供一般性机械拦截作用,还利用自身所带电荷产生的库伦力实现对颗粒的捕获,且过滤效率远高于普通纤维,尤其在过滤亚微米级颗粒时更加明显。Ordinary fiber filter materials mainly rely on mechanical interception such as Brownian diffusion, interception, inertial collision, and gravity sedimentation to filter particles in the air, but the filtering effect of sub-micron particles is not ideal. Therefore, an electret is often added to the fiber, which not only provides a general mechanical interception effect, but also uses the Coulomb force generated by its own charge to capture particles, and the filtration efficiency is much higher than that of ordinary fibers, especially in filtering sub-micron. It is more obvious when the particles are graded.
常用的驻极体材料分为无机和有机两大类:无机驻极体材料包括电气石类、磁化物、无机硅等,存在应用效果不佳、成本高等问题;有机驻极体材料包括有机玻璃、高分子聚合物等,面临难以降解、储存的电荷衰减严重等问题。作为天然的生物驻极体材料,骨骼、蛋白质等材料能够长期保持极化或带电状态,因而,亟需具有优异生物相容性、对人体和环境友好的高电荷存储型生物驻极体材料。Commonly used electret materials are divided into two categories: inorganic and organic: inorganic electret materials include tourmaline, magnets, inorganic silicon, etc., which have problems of poor application effect and high cost; organic electret materials include plexiglass , high-molecular polymers, etc., face the problems of difficult degradation and serious decay of stored charge. As natural bio-electret materials, materials such as bone and protein can maintain a polarized or charged state for a long time. Therefore, high-charge-storage bio-electret materials with excellent biocompatibility and friendliness to the human body and the environment are urgently needed.
羟基磷灰石是人体和动物骨骼的主要无机成分,它能与机体组织在界面上实现化学键性结合,在体内有一定的溶解度,能释放对机体无害的离子并参与体内代谢,具有优良的生物相容性和生物活性。在不同条件下,其晶体呈颗粒状、纤维状、针状或纤维集合状,直径可低至数纳米,长度可达数毫米。较高的离子活性赋予了羟基磷灰石良好的极化潜能,利于实施快速、简便的驻极效应,从而获得较高的表面电位和过滤效果。Hydroxyapatite is the main inorganic component of human and animal bones. It can achieve chemical bonding with body tissues at the interface, has a certain solubility in the body, can release ions that are harmless to the body and participate in body metabolism. It has excellent properties. Biocompatibility and Bioactivity. Under different conditions, its crystals are granular, fibrous, needle-like or fibrous aggregates, with diameters as low as several nanometers and lengths up to several millimeters. The higher ionic activity endows the hydroxyapatite with good polarization potential, which facilitates the implementation of a fast and simple electret effect, resulting in a higher surface potential and filtration effect.
因此,提供一种通过雾化、沉积的方式均匀引入聚乳酸静电纺丝纳米纤维膜,从而实现全降解型纳米纤维膜的高性能化与多功能化的生物驻极体在聚乳酸纳米纤维表面均分布的长效过滤膜及其制备方法,已是一个值得研究的问题。Therefore, to provide a bio-electret that is uniformly introduced into the polylactic acid electrospinning nanofiber membrane by atomization and deposition, so as to realize the high performance and multifunctionalization of the fully degradable nanofiber membrane on the surface of the polylactic acid nanofiber The uniform distribution of long-term filter membrane and its preparation method is a problem worthy of study.
发明内容SUMMARY OF THE INVENTION
本发明的目的是提供一种通过雾化、沉积的方式均匀引入聚乳酸静电纺丝纳米纤维膜,从而实现全降解型纳米纤维膜的高性能化与多功能化的生物驻极体在聚乳酸纳米纤维表面均分布的长效过滤膜及其制备方法。The purpose of the present invention is to provide a kind of bio-electret which is uniformly introduced into polylactic acid electrospinning nanofiber membrane by means of atomization and deposition, so as to realize the high performance and multifunctionalization of fully degradable nanofiber membrane in polylactic acid. A long-term filter membrane with uniform distribution on the surface of nanofibers and a preparation method thereof.
本发明的目的是这样实现的:The object of the present invention is achieved in this way:
一种生物驻极体在聚乳酸纳米纤维表面均分布的长效过滤膜,包括聚乳酸纤维膜,所述聚乳酸纳米纤维膜表面均匀分布有生物驻极体,所述聚乳酸纳米纤维中生物驻极体含量为0.05~30 wt %,所述生物驻极体为微波辅助仿生矿化合成的羟基磷灰石纳米晶须。A long-term filtration membrane in which biological electrets are evenly distributed on the surface of polylactic acid nanofibers, including a polylactic acid fiber membrane, the surface of the polylactic acid nanofiber membrane is evenly distributed with biological electrets, and biological electrets are evenly distributed on the surface of the polylactic acid nanofibers. The electret content is 0.05-30 wt %, and the biological electret is a hydroxyapatite nanowhisker synthesized by microwave-assisted biomimetic mineralization.
所述羟基磷灰石纳米晶须的直径1~20 nm,所述羟基磷灰石纳米晶须的长径比5~200。The diameter of the hydroxyapatite nanowhisker is 1-20 nm, and the aspect ratio of the hydroxyapatite nanowhisker is 5-200.
所述聚乳酸纤维膜的厚度为40~800 μm,所述聚乳酸纤维膜中纳米纤维的直径为5~100 nm。The thickness of the polylactic acid fiber film is 40-800 μm, and the diameter of the nanofibers in the polylactic acid fiber film is 5-100 nm.
一种生物驻极体在聚乳酸纳米纤维表面均分布的长效过滤膜的制备方法,包括以下步骤:A preparation method of a long-term filtration membrane in which biological electrets are evenly distributed on the surface of polylactic acid nanofibers, comprising the following steps:
S1. 制备羟基磷灰石纳米晶须:将水溶性钙盐、水溶性磷酸盐和模板剂加入水中,搅拌溶解均匀后,置入微波反应釜中,在搅拌状态下,进行微波辅助的仿生矿化反应,反应结束后冷却,得到沉积有羟基磷灰石纳米晶须的水溶液;S1. Preparation of hydroxyapatite nanowhiskers: add water-soluble calcium salt, water-soluble phosphate and template agent into water, stir and dissolve evenly, put it into a microwave reactor, and conduct microwave-assisted biomimetic mineralization under stirring chemical reaction, and cooling after the reaction finishes to obtain an aqueous solution deposited with hydroxyapatite nanowhiskers;
S2. 制备羟基磷灰石纳米晶须分散液:采用等离子体设备直接处理步骤S1所得羟基磷灰石纳米晶须水溶液,获得羟基磷灰石纳米晶须分散液;S2. Preparation of hydroxyapatite nanowhisker dispersion: using plasma equipment to directly process the hydroxyapatite nanowhisker aqueous solution obtained in step S1 to obtain a hydroxyapatite nanowhisker dispersion;
S3. 制备生物驻极体均分布的聚乳酸纳米纤维膜:将溶于有机溶剂的聚乳酸通过静电纺丝技术制备纳米纤维膜,并在纺丝过程中施加雾化的步骤S2羟基磷灰石纳米晶须分散液,得到生物驻极体均分布的聚乳酸纳米纤维膜。S3. Preparation of polylactic acid nanofiber membrane with uniform distribution of biological electrets: polylactic acid dissolved in organic solvent is prepared by electrospinning technology to prepare nanofiber membrane, and the step of atomization is applied during the spinning process. S2 hydroxyapatite The nano-whisker dispersion liquid is obtained to obtain a polylactic acid nanofiber membrane with a uniform distribution of biological electrets.
所述步骤S1中水溶性钙盐为氯化钙、硝酸钙、醋酸钙、次氯酸钙中的至少一种,水溶性钙盐的浓度为0.01~2摩尔/升;水溶性磷酸盐为磷酸二氢铵、磷酸氢铵、磷酸氢二钠、磷酸二氢钠、磷酸氢二钾、磷酸二氢钾中的至少一种,钙离子与磷酸根离子的摩尔比为2:1~1:1;板剂为溴化十六烷基三甲铵、硬脂酸、油酸、十二烷基硫酸钠、十二烷基苯磺酸钠和辛基苯基聚氧乙烯醚中的至少一种,模板剂在溶液中质量分数为0.001 wt %~0.1 wt %,能够作为结构导向剂使羟基磷灰石沿c轴生长为棒状一维纳米晶须。In the step S1, the water-soluble calcium salt is at least one of calcium chloride, calcium nitrate, calcium acetate, and calcium hypochlorite, and the concentration of the water-soluble calcium salt is 0.01 to 2 mol/liter; the water-soluble phosphate is phosphoric acid At least one of ammonium dihydrogen phosphate, ammonium hydrogen phosphate, disodium hydrogen phosphate, sodium dihydrogen phosphate, dipotassium hydrogen phosphate, potassium dihydrogen phosphate, and the molar ratio of calcium ion to phosphate ion is 2:1~1:1 ; The plate agent is at least one of cetyltrimethylammonium bromide, stearic acid, oleic acid, sodium lauryl sulfate, sodium dodecylbenzenesulfonate and octylphenyl polyoxyethylene ether, The mass fraction of the template agent in the solution is 0.001 wt %~0.1 wt %, which can act as a structure directing agent to grow hydroxyapatite into rod-like one-dimensional nanowhiskers along the c-axis.
所述步骤S1中微波辅助合成的反应温度为100~250 ℃,反应时间1~30分钟;步骤S1所得羟基磷灰石纳米晶须的直径为1~20 nm,长径比为5~200。In the step S1, the reaction temperature of the microwave-assisted synthesis is 100-250 °C, and the reaction time is 1-30 minutes; the diameter of the hydroxyapatite nanowhisker obtained in the step S1 is 1-20 nm, and the aspect ratio is 5-200.
所述步骤S2中等离子体处理设备为常压射流式、介质阻挡放电式、旋转型常压式中的至少一种,所述等离子体放电电压为1~80 kV,等离子体工作气为氩气、氦气、氢气、氮气、氧气中的至少一种,处理温度为10~50 ℃,处理温度为10秒~30分钟。In the step S2, the plasma processing equipment is at least one of the normal pressure jet type, the dielectric barrier discharge type, and the rotary type normal pressure type, the plasma discharge voltage is 1-80 kV, and the plasma working gas is argon. , at least one of helium, hydrogen, nitrogen, and oxygen, and the treatment temperature is 10 to 50 °C, and the treatment temperature is 10 seconds to 30 minutes.
所述步骤S3中有机溶剂为二氯甲烷、三氯甲烷、二甲基甲酰胺、N-甲基吡咯烷酮、六氟异丙醇、甲醇、乙醇、异丙醇、丙三醇中的至少一种,混合溶液中聚乳酸浓度为0.5~22wt %;静电纺丝的模块电压为15~60 kV,接收电压为–15~0 kV,纺丝原液消耗速率为1~60mL/min。In the step S3, the organic solvent is at least one of methylene chloride, trichloromethane, dimethylformamide, N-methylpyrrolidone, hexafluoroisopropanol, methanol, ethanol, isopropanol, and glycerol , the polylactic acid concentration in the mixed solution was 0.5-22 wt %; the electrospinning module voltage was 15-60 kV, the receiving voltage was –15-0 kV, and the spinning dope consumption rate was 1-60 mL/min.
所述步骤S3中生物驻极体的雾化速度为0.5~50 mL/min,所得生物驻极体改性聚乳酸纳米纤维直径为5~100 nm,所述聚乳酸纳米纤维中生物驻极体含量为0.05~30 wt %,所得聚乳酸纤维膜厚度为40~800 μm。In the step S3, the atomization speed of the bio-electret is 0.5-50 mL/min, the diameter of the obtained bio-electret-modified polylactic acid nanofiber is 5-100 nm, and the bio-electret in the polylactic acid nanofiber has a diameter of 5-100 nm. The content is 0.05-30 wt %, and the thickness of the obtained PLA fiber film is 40-800 μm.
本发明的有益效果是:本发明提出了高效合成生物驻极体并使其具有高表面活性、高分散性和在纤维表面均分布的技术路线,为提高聚乳酸纳米纤维膜表面电位和静电吸附效果提供了新途径,有助拓展可降解高分子材料在长效空气过滤材料领域的应用与发展。The beneficial effects of the present invention are as follows: the present invention proposes a technical route for efficiently synthesizing biological electrets with high surface activity, high dispersibility and uniform distribution on the fiber surface, in order to improve the surface potential and electrostatic adsorption of polylactic acid nanofiber membranes The effect provides a new way to help expand the application and development of degradable polymer materials in the field of long-term air filter materials.
附图说明Description of drawings
图1为本发明的流程图;Fig. 1 is the flow chart of the present invention;
图2为本发明透射电子显微镜观察实施例1中等离子体处理溶液的羟基磷灰石纳米晶须形态;Fig. 2 is the hydroxyapatite nanowhisker morphology of the plasma treatment solution observed in Example 1 by transmission electron microscope of the present invention;
图3为本发明扫描电子显微镜观察对比例1中市售常规羟基磷灰石的图像;Fig. 3 is the image of commercially available conventional hydroxyapatite in comparative example 1 observed by scanning electron microscope of the present invention;
图4为本发明扫描电子显微镜观察实施例1中所得聚乳酸纤维膜的图像;Fig. 4 is the image of the polylactic acid fiber film obtained in Example 1 observed by scanning electron microscope of the present invention;
图5为本发明扫描电子显微镜观察对比例1中所得聚乳酸纤维膜的图像。5 is an image of the polylactic acid fiber membrane obtained in Comparative Example 1 observed by a scanning electron microscope of the present invention.
具体实施方式Detailed ways
以下结合附图和实施例对本发明作进一步说明。The present invention will be further described below with reference to the accompanying drawings and embodiments.
实施例1:Example 1:
如图1所示一种生物驻极体在聚乳酸纳米纤维表面均分布的长效过滤膜及其制备方法,包括以下步骤:As shown in Figure 1, a long-term filtration membrane in which biological electrets are uniformly distributed on the surface of polylactic acid nanofibers and a preparation method thereof, comprising the following steps:
S1. 制备羟基磷灰石纳米晶须:将氯化钙(0.01摩尔/升)、磷酸二氢铵(0.01摩尔/升)和硬脂酸(0.001 wt %)加入水中,混合均匀后,置入微波反应釜中,在搅拌状态下,升温至250 ℃,反应1分钟,反应结束后冷却,得到沉积有羟基磷灰石纳米晶须的水溶液;S1. Preparation of hydroxyapatite nanowhiskers: add calcium chloride (0.01 mol/L), ammonium dihydrogen phosphate (0.01 mol/L) and stearic acid (0.001 wt %) into water, mix well, put In the microwave reaction kettle, in a stirring state, the temperature is raised to 250 ° C, the reaction is performed for 1 minute, and the reaction is cooled to obtain an aqueous solution with hydroxyapatite nanowhiskers deposited;
S2. 制备羟基磷灰石纳米晶须分散液:采用介质阻挡放电式等离子体设备(工作电压1 kV,工作气为氩气/氮气混合气,温度15~30 ℃),将S1所得水溶液处理30分钟,获得羟基磷灰石纳米晶须分散液;S2. Preparation of hydroxyapatite nanowhisker dispersion: Using dielectric barrier discharge plasma equipment (working voltage 1 kV, working gas is argon/nitrogen gas mixture, temperature 15~30 ℃), the aqueous solution obtained from S1 was treated for 30 minutes to obtain a hydroxyapatite nanowhisker dispersion;
S3. 制备生物驻极体均分布的聚乳酸纳米纤维膜:将聚乳酸在二氯甲烷/N-甲基吡咯烷酮(质量比7:3)中溶解后作为纺丝原液,通过静电纺丝技术(模块电压20 kV,接收电压–15 kV,原液消耗速率0.5 mL/min)制备纳米纤维,同时将S2所得分散液进行雾化(速度0.5 mL/min),直至生物驻极体含量达到0.05 wt %,纤维膜厚度达到800 μm。S3. Preparation of polylactic acid nanofiber membrane with uniform distribution of biological electrets: polylactic acid was dissolved in dichloromethane/N-methylpyrrolidone (mass ratio 7:3) as a spinning dope, and electrospinning technology ( The module voltage was 20 kV, the receiving voltage was –15 kV, and the consumption rate of the stock solution was 0.5 mL/min) to prepare nanofibers, while the dispersion obtained from S2 was atomized (speed 0.5 mL/min) until the bioelectret content reached 0.05 wt % , the fiber membrane thickness reaches 800 μm.
实施例2Example 2
一种生物驻极体在聚乳酸纳米纤维表面均分布的长效过滤膜及其制备方法,包括以下步骤:A long-acting filter membrane in which biological electrets are evenly distributed on the surface of polylactic acid nanofibers and a preparation method thereof, comprising the following steps:
S1. 制备羟基磷灰石纳米晶须:将硝酸钙(2摩尔/升)、磷酸氢二钠(1摩尔/升)和油酸(0.1 wt %)加入水中,混合均匀后,置入微波反应釜中,在搅拌状态下,升温至100 ℃,反应30分钟,反应结束后冷却,得到沉积有羟基磷灰石纳米晶须的水溶液;S1. Preparation of hydroxyapatite nanowhiskers: calcium nitrate (2 mol/L), disodium hydrogen phosphate (1 mol/L) and oleic acid (0.1 wt %) were added to water, mixed well, and placed in a microwave reaction In the kettle, under stirring, the temperature was raised to 100° C., reacted for 30 minutes, and cooled after the reaction to obtain an aqueous solution deposited with hydroxyapatite nanowhiskers;
S2. 制备羟基磷灰石纳米晶须分散液:采用旋转型常压式等离子体设备(工作电压80 kV,工作气为氩气,温度25~35 ℃),将S21所得水溶液处理10分钟,获得羟基磷灰石纳米晶须分散液;S2. Preparation of hydroxyapatite nanowhisker dispersion: using a rotary atmospheric pressure plasma equipment (working voltage 80 kV, working gas argon, temperature 25-35 °C), the aqueous solution obtained in S21 was treated for 10 minutes to obtain Hydroxyapatite nanowhisker dispersion;
S3. 制备生物驻极体均分布的聚乳酸纳米纤维膜:将聚乳酸在三氯甲烷/二甲基甲酰胺(质量比6:4)中溶解后作为纺丝原液,通过静电纺丝技术(模块电压60 kV,接收电压0 kV,原液消耗速率60 mL/min)制备纳米纤维,同时将S22所得分散液进行雾化(速度50mL/min),直至生物驻极体含量达到30 wt %,纤维膜厚度达到40 μm。S3. Preparation of polylactic acid nanofiber membrane with uniform distribution of biological electrets: polylactic acid was dissolved in chloroform/dimethylformamide (mass ratio 6:4) as a spinning dope, and electrospinning technology ( The module voltage was 60 kV, the receiving voltage was 0 kV, and the stock solution consumption rate was 60 mL/min) to prepare nanofibers. At the same time, the dispersion obtained from S22 was atomized (
实施例3Example 3
如图1所示,一种生物驻极体在聚乳酸纳米纤维表面均分布的长效过滤膜及其制备方法,包括以下步骤:As shown in Figure 1, a long-acting filtration membrane in which biological electrets are uniformly distributed on the surface of polylactic acid nanofibers and a preparation method thereof, comprising the following steps:
S1. 制备羟基磷灰石纳米晶须:将醋酸钙(0.05摩尔/升)、磷酸二氢钾(0.04摩尔/升)和溴化十六烷基三甲铵(0.01 wt %)加入水中,混合均匀后,置入微波反应釜中,在搅拌状态下,升温至150 ℃,反应15分钟,反应结束后冷却,得到沉积有羟基磷灰石纳米晶须的水溶液;S1. Preparation of hydroxyapatite nanowhiskers: add calcium acetate (0.05 mol/L), potassium dihydrogen phosphate (0.04 mol/L) and cetyltrimethylammonium bromide (0.01 wt%) into water and mix well Then, it was placed in a microwave reactor, heated to 150° C. under stirring, and reacted for 15 minutes, and cooled after the reaction to obtain an aqueous solution deposited with hydroxyapatite nanowhiskers;
S2. 制备羟基磷灰石纳米晶须分散液:采用常压射流式等离子体设备(工作电压20 kV,工作气为氩气,温度25~50 ℃),将S1所得水溶液处理30分钟,获得羟基磷灰石纳米晶须分散液;S2. Preparation of hydroxyapatite nanowhisker dispersion: Using atmospheric jet plasma equipment (working voltage 20 kV, working gas argon, temperature 25-50 °C), the aqueous solution obtained in S1 was treated for 30 minutes to obtain hydroxyl groups Apatite nanowhisker dispersion;
S3. 制备生物驻极体均分布的聚乳酸纳米纤维膜:将聚乳酸在二甲基甲酰胺/六氟异丙醇(质量比5:5)中溶解后作为纺丝原液,通过静电纺丝技术(模块电压40 kV,接收电压–10 kV,原液消耗速率30 mL/min)制备纳米纤维,同时将S2所得分散液进行雾化(速度30mL/min),直至生物驻极体含量达到10 wt %,纤维膜厚度达到80 μm。S3. Preparation of polylactic acid nanofiber membrane with uniform distribution of biological electrets: polylactic acid was dissolved in dimethylformamide/hexafluoroisopropanol (mass ratio 5:5) as a spinning dope, and electrospinned by electrospinning Technology (module voltage 40 kV, receiving voltage –10 kV, stock solution consumption rate 30 mL/min) to prepare nanofibers, while the dispersion obtained from S2 was atomized (speed 30 mL/min) until the biological electret content reached 10 wt %, and the thickness of the fiber membrane reaches 80 μm.
实施例4Example 4
一种生物驻极体在聚乳酸纳米纤维表面均分布的长效过滤膜及其制备方法,包括以下步骤:A long-acting filter membrane in which biological electrets are evenly distributed on the surface of polylactic acid nanofibers and a preparation method thereof, comprising the following steps:
S1. 制备羟基磷灰石纳米晶须:将次氯酸钙(0.2摩尔/升)、磷酸氢铵(0.15摩尔/升)和辛基苯基聚氧乙烯醚(0.05 wt %)加入水中,混合均匀后,置入微波反应釜中,在搅拌状态下,升温至200 ℃,反应5分钟,反应结束后冷却,得到沉积有羟基磷灰石纳米晶须的水溶液;S1. Preparation of hydroxyapatite nanowhiskers: calcium hypochlorite (0.2 mol/L), ammonium hydrogen phosphate (0.15 mol/L) and octylphenylethoxylate (0.05 wt%) were added to water, mixed After homogeneous, put it into a microwave reactor, under stirring, heat up to 200 ° C, react for 5 minutes, and cool down after the reaction to obtain an aqueous solution with hydroxyapatite nanowhiskers deposited;
S2. 制备羟基磷灰石纳米晶须分散液:采用介质阻挡放电式等离子体设备(工作电压40 kV,工作气为氩气/氮气混合气,温度20~40 ℃),将S1所得水溶液处理15分钟,获得羟基磷灰石纳米晶须分散液;S2. Preparation of hydroxyapatite nanowhisker dispersion: Using dielectric barrier discharge plasma equipment (working voltage 40 kV, working gas is argon/nitrogen gas mixture, temperature 20~40 °C), the aqueous solution obtained from S1 was treated for 15 minutes to obtain a hydroxyapatite nanowhisker dispersion;
S3. 制备生物驻极体均分布的聚乳酸纳米纤维膜:将聚乳酸在N-甲基吡咯烷酮/二甲基甲酰胺(质量比7:3)中溶解后作为纺丝原液,通过静电纺丝技术(模块电压35 kV,接收电压0 kV,原液消耗速率20 mL/min)制备纳米纤维,同时将S2所得分散液进行雾化(速度10 mL/min),直至生物驻极体含量达到15 wt %,纤维膜厚度达到100 μm。S3. Preparation of polylactic acid nanofiber membrane with uniform distribution of biological electrets: polylactic acid was dissolved in N-methylpyrrolidone/dimethylformamide (mass ratio 7:3) as a spinning dope, and electrospinned by electrospinning Technology (module voltage 35 kV, receiving voltage 0 kV, stock solution consumption rate 20 mL/min) to prepare nanofibers, while the dispersion obtained from S2 was atomized (speed 10 mL/min) until the biological electret content reached 15 wt %, and the thickness of the fiber membrane reaches 100 μm.
实施例5Example 5
一种生物驻极体在聚乳酸纳米纤维表面均分布的长效过滤膜及其制备方法,包括以下步骤:A long-acting filter membrane in which biological electrets are evenly distributed on the surface of polylactic acid nanofibers and a preparation method thereof, comprising the following steps:
S1. 制备羟基磷灰石纳米晶须:将醋酸钙(0.8摩尔/升)、磷酸二氢铵(0.5摩尔/升)和十二烷基苯磺酸钠(0.08 wt %)加入水中,混合均匀后,置入微波反应釜中,在搅拌状态下,升温至140 ℃,反应20分钟,反应结束后冷却,得到沉积有羟基磷灰石纳米晶须的水溶液;S1. Preparation of hydroxyapatite nanowhiskers: add calcium acetate (0.8 mol/L), ammonium dihydrogen phosphate (0.5 mol/L) and sodium dodecylbenzenesulfonate (0.08 wt %) into water and mix well Then, put it into a microwave reaction kettle, and under stirring, the temperature was raised to 140° C., reacted for 20 minutes, and cooled after the reaction was completed to obtain an aqueous solution deposited with hydroxyapatite nanowhiskers;
S2. 制备羟基磷灰石纳米晶须分散液:采用介质阻挡放电式等离子体设备(工作电压10 kV,工作气为氦气,温度20~30 ℃),将S1所得水溶液处理25分钟,获得羟基磷灰石纳米晶须分散液;S2. Preparation of hydroxyapatite nanowhisker dispersion: Using dielectric barrier discharge plasma equipment (working voltage 10 kV, working gas is helium, temperature 20-30 °C), the aqueous solution obtained in S1 was treated for 25 minutes to obtain hydroxyl groups Apatite nanowhisker dispersion;
S3. 制备生物驻极体均分布的聚乳酸纳米纤维膜:将聚乳酸在二氯甲烷/六氟异丙醇(质量比9:1)中溶解后作为纺丝原液,通过静电纺丝技术(模块电压45 kV,接收电压0kV,原液消耗速率20 mL/min)制备纳米纤维,同时将S2所得分散液进行雾化(速度15 mL/min),直至生物驻极体含量达到18 wt %,纤维膜厚度达到500 μm。S3. Preparation of polylactic acid nanofiber membrane with uniform distribution of biological electrets: polylactic acid was dissolved in dichloromethane/hexafluoroisopropanol (mass ratio 9:1) as a spinning dope, and electrospinning technology ( The module voltage was 45 kV, the receiving voltage was 0 kV, and the stock solution consumption rate was 20 mL/min) to prepare nanofibers, and the dispersion obtained from S2 was atomized at the same time (speed 15 mL/min) until the biological electret content reached 18 wt %. The film thickness reaches 500 μm.
对比例1(添加常规羟基磷灰石填料)Comparative example 1 (adding conventional hydroxyapatite filler)
基本采用实施例1的方法制备羟基磷灰石分散液和聚乳酸纤维膜。不同的是,本例不采用微波辅助仿生矿化方法合成的羟基磷灰石纳米晶须,而是添加市售的羟基磷灰石粉末(纯度99%,平均直径2 nm,西安通泽生物科技有限公司)。具体地,直接将羟基磷灰石粉末在水中搅拌分散后,采用介质阻挡放电式等离子体设备(工作电压1 kV,工作气为氩气/氮气混合气,温度15~30 ℃),处理30分钟,获得稳定分散的水溶液;将聚乳酸在二氯甲烷/N-甲基吡咯烷酮(质量比7:3)中溶解后作为纺丝原液,通过静电纺丝技术(模块电压20 kV,接收电压–15 kV,原液消耗速率0.5 mL/min)制备纳米纤维,同时将羟基磷灰石的分散液进行雾化(速度0.5 mL/min),直至羟基磷灰石的含量达到0.05 wt %,纤维膜厚度达到800 μm。The method of Example 1 was basically used to prepare the hydroxyapatite dispersion and the polylactic acid fiber membrane. The difference is that this example does not use the hydroxyapatite nanowhisker synthesized by the microwave-assisted biomimetic mineralization method, but adds commercially available hydroxyapatite powder (purity 99%, average diameter 2 nm, Xi'an Tongze Biotechnology). Ltd). Specifically, after directly stirring and dispersing the hydroxyapatite powder in water, a dielectric barrier discharge plasma equipment (working voltage of 1 kV, working gas of argon/nitrogen gas mixture, temperature of 15-30 °C) was used for 30 minutes. , to obtain a stably dispersed aqueous solution; polylactic acid was dissolved in dichloromethane/N-methylpyrrolidone (mass ratio 7:3) as a spinning dope, and electrospinning technology (module voltage 20 kV, receiving voltage –15 At the same time, the dispersion of hydroxyapatite was atomized (speed 0.5 mL/min) until the content of hydroxyapatite reached 0.05 wt % and the thickness of the fiber film reached 0.05 wt %. 800 μm.
对比例2(不采用等离子体处理技术分散生物驻极体)Comparative Example 2 (without using plasma treatment technology to disperse the biological electret)
基本采用实施例2的方法制备生物驻极体和聚乳酸纳米纤维膜。不同的是,本例不采用等离子体处理技术分散羟基磷灰石纳米晶须。具体地,将聚乳酸在三氯甲烷/二甲基甲酰胺(质量比6:4)中溶解后作为纺丝原液,通过静电纺丝技术(模块电压60 kV,接收电压0kV,原液消耗速率60 mL/min)制备纳米纤维,同时将S21所得分散液进行雾化(速度50 mL/min),直至生物驻极体含量达到30 wt %,纤维膜厚度达到40 μm。Basically, the method of Example 2 was used to prepare biological electret and polylactic acid nanofiber membrane. The difference is that this example does not use plasma treatment technology to disperse hydroxyapatite nanowhiskers. Specifically, polylactic acid was dissolved in chloroform/dimethylformamide (mass ratio 6:4) as a spinning dope solution, and electrospinning technology (module voltage 60 kV, receiving voltage 0 kV, dope consumption rate 60 mL/min) to prepare nanofibers, while the dispersion obtained from S21 was atomized (
对比例3(不添加生物驻极体)Comparative Example 3 (without adding biological electret)
基本采用实施例3的方法制备聚乳酸纳米纤维膜,不同的是,本例未添加任何驻极体。具体地,将聚乳酸在二甲基甲酰胺/六氟异丙醇(质量比5:5)中溶解后作为纺丝原液,通过静电纺丝技术(模块电压40 kV,接收电压–10 kV,原液消耗速率30 mL/min)制备纳米纤维,直至纤维膜厚度达到80 μm。The polylactic acid nanofiber membrane was basically prepared by the method of Example 3, except that no electret was added in this example. Specifically, polylactic acid was dissolved in dimethylformamide/hexafluoroisopropanol (mass ratio 5:5) as a spinning dope, and electrospinning technology (module voltage 40 kV, receiving voltage -10 kV, The stock solution consumption rate was 30 mL/min) to prepare nanofibers until the thickness of the fiber membrane reached 80 μm.
结构表征和性能测试Structural Characterization and Performance Testing
透射电子显微镜观察:使用透射电镜(型号Hitachi HT7700,日立电子,日本)观察等离子体处理羟基磷灰石纳米晶须的微观结构和分散形态(图2)。Transmission electron microscope observation: The microstructure and dispersed morphology of plasma-treated hydroxyapatite nanowhiskers were observed using a transmission electron microscope (model Hitachi HT7700, Hitachi Electronics, Japan) (Fig. 2).
扫描电子显微镜观察:通过场发射扫描电子显微镜(型号JSM-7900F,日本电子)观察市售常规的羟基磷灰石纳米颗粒的微观结构(图3),以及聚乳酸纤维膜的微观结构(图4和5)。Scanning electron microscope observation: The microstructure of commercially available conventional hydroxyapatite nanoparticles (Fig. 3), and the microstructure of the polylactic acid fiber film (Fig. 4) were observed by a field emission scanning electron microscope (model JSM-7900F, JEOL). and 5).
拉伸性能测试:将所得纤维膜裁剪后获得拉伸样条,根据美国材料试验协会的ASTM D638-2003中塑料拉伸性能测试标准,使用美国Instron公司的万能拉伸机(型号4403,传感器100 N)对复合材料的拉伸性能进行测试。每组至少保证3个平行的测试样品,结果取其平均值。Tensile property test: The obtained fiber film was cut out to obtain a tensile spline, according to the plastic tensile property test standard in ASTM D638-2003 of the American Society for Testing and Materials, using a universal tensile machine (model 4403, sensor 100 from Instron, USA) N) Testing the tensile properties of the composites. At least 3 parallel test samples are guaranteed for each group, and the average value of the results is taken.
表面电位测试:采用非接触式静电仪(VM54XQS,美国Quatek公司)测试纳米纤维膜(面积100 mm2)的表面电位,测试高度为2 cm,温度和湿度恒定为25 ℃和45%,每个样品随机采集20个数据点并取其平均值。Surface potential test: A non-contact electrostatic meter (VM54XQS, Quatek, USA) was used to test the surface potential of the nanofiber membrane (area 100 mm2), the test height was 2 cm, and the temperature and humidity were constant at 25 °C and 45% for each sample. Twenty data points were randomly collected and averaged.
过滤性能测试:采用LZC-K型自动滤料测试仪(苏州华达仪器设备有限公司)测试纳米纤维膜(面积100 cm2)的空气过滤性能,气体流速设置为85 L/min,气溶胶发生器产生的NaCl雾化颗粒的粒径范围为0.1~10 μm。每组纤维膜至少测试3个不同位置,结果取其平均值。Filtration performance test: LZC-K automatic filter material tester (Suzhou Huada Instrument Equipment Co., Ltd.) was used to test the air filtration performance of the nanofiber membrane (area 100 cm2), the gas flow rate was set to 85 L/min, and the aerosol generator was used. The resulting NaCl atomized particles ranged in size from 0.1 to 10 μm. At least 3 different positions were tested for each group of fibrous membranes, and the results were averaged.
表1. 聚乳酸纳米纤维膜的力学性能和过滤性能测试结果Table 1. Test results of mechanical properties and filtration performance of PLA nanofiber membranes
实验结果:如图2所示,通过微波辅助仿生矿化合成的羟基磷灰石纳米晶须具有良好的结构规整度和结晶性,晶须直径和长径比也得到良好控制,奠定了其作为生物驻极体的结构基础,同时结合等离子体处理,可获得良好的分散形态。与此形成明显对比的是,市售羟基磷灰石纳米颗粒存在明显团聚,难以获得良好分散形态(图3)。Experimental results: As shown in Fig. 2, the hydroxyapatite nanowhisker synthesized by microwave-assisted biomimetic mineralization has good structural regularity and crystallinity, and the whisker diameter and aspect ratio are also well controlled, which lays a solid foundation for its role as a nano-whisker. Structural basis of biological electrets, and in combination with plasma treatment, good dispersion morphology can be obtained. In obvious contrast, the commercially available hydroxyapatite nanoparticles have obvious agglomeration, and it is difficult to obtain a good dispersed morphology (Figure 3).
如图4所示,将等离子体处理的羟基磷灰石纳米晶须分散液进行雾化,和静电纺丝技术相结合,可实现生物驻极体在聚乳酸纳米纤维表面的均匀分布,聚乳酸纤维直径为纳米级别,且分布较为均一(15~90 nm),而生物驻极体在纳米纤维表面均匀分布,且与纤维有较强的界面结合力,保证纤维高孔隙率和良好三维连通结构,同时提高纳米纤维力学性能、表面电位和过滤效率。图5表明,羟基磷灰石的表面性质和几何尺寸也展现了较为重要的影响:常规市售的纳米羟基磷灰石在引入后极易形成局部团聚,更导致纤维直径分布不均,出现了大量微米级纤维结构。As shown in Figure 4, the atomization of the plasma-treated hydroxyapatite nanowhisker dispersion and the combination of electrospinning technology can achieve uniform distribution of biological electrets on the surface of PLA nanofibers. The diameter of the fiber is nanometer, and the distribution is relatively uniform (15~90 nm), while the biological electret is evenly distributed on the surface of the nanofiber, and has a strong interfacial bonding force with the fiber, ensuring high fiber porosity and good three-dimensional connected structure. , while improving the mechanical properties, surface potential and filtration efficiency of nanofibers. Figure 5 shows that the surface properties and geometric dimensions of hydroxyapatite also have important effects: the conventional commercially available nano-hydroxyapatite is very easy to form local agglomeration after introduction, which leads to uneven distribution of fiber diameters, and A large number of micron-scale fibrous structures.
表1比较了实施例和比较例所得聚乳酸纳米纤维膜的拉伸测试、表面电位测试和过滤性测试结果,实施例1‒5均具有较高的断裂强度(4.6 MPa‒8.6 MPa),数倍于纯聚乳酸纤维膜(2.6 MPa),体现了优异的力学性能,完全满足聚乳酸纤维膜在过滤材料领域的力学性能要求。然而,对比例1和2的断裂强度仅为3.0 MPa和4.2 MPa,主要是由于纳米颗粒性质不可控或分散方法不适导致的严重团聚。Table 1 compares the tensile test, surface potential test and filterability test results of the polylactic acid nanofiber membranes obtained in the examples and comparative examples. It is twice as high as the pure PLA fiber membrane (2.6 MPa), which reflects the excellent mechanical properties and fully meets the mechanical properties requirements of the PLA fiber membrane in the field of filter materials. However, the breaking strengths of Comparative Examples 1 and 2 were only 3.0 MPa and 4.2 MPa, mainly due to severe agglomeration caused by uncontrollable nanoparticle properties or unsuitable dispersion methods.
同样具有重要意义的是,实施例1‒5均展现了极高的表面电位(6.2 kV~14.5 kV),且随时间几乎不产生衰减,证实具有极高的长效稳定性。尤其是实施例2的表面电位初始值高至14.5 kV,是对比例2的2.23倍、对比例3的近4.53倍;且在90天后,实施例2的表面电位仍保持在13.9 kV,而对比例2和3大幅衰减至0.5 kV和0.2 kV。生物驻极体的分散程度和聚乳酸纳米纤维膜的表面电位与过滤性能密切相关,具有最高表面电位的实施例2在过滤测试中表现最为优异,PM0.3和PM2.5的过滤效率分别达到99.7%和99.9%;远高于表面电位较低的对比例1–3(PM0.3和PM2.5的过滤效率均<90%)。It is also of great significance that Examples 1–5 all exhibit extremely high surface potential (6.2 kV~14.5 kV), and almost no decay occurs over time, confirming that they have extremely high long-term stability. In particular, the initial value of the surface potential of Example 2 was as high as 14.5 kV, which was 2.23 times that of Comparative Example 2 and nearly 4.53 times that of Comparative Example 3; and after 90 days, the surface potential of Example 2 remained at 13.9 kV, while the Ratios 2 and 3 attenuate substantially to 0.5 kV and 0.2 kV. The degree of dispersion of the biological electret and the surface potential of the PLA nanofiber membrane are closely related to the filtration performance. Example 2 with the highest surface potential performed the best in the filtration test, and the filtration efficiency of PM0. 99.7% and 99.9%; much higher than the comparative examples 1–3 with lower surface potential (the filtration efficiencies of PM0.3 and PM2.5 are both <90%).
由此说明,本发明提出的技术方案使得生物驻极体具有良好的表面性质和结构规整度,以及在聚乳酸纳米纤维中分散程度和功效发挥都得到了明显改善,这些得益于:(1)微波辅助仿生矿化合成羟基磷灰石纳米晶须的结构规整度和均一性,使其在聚乳酸中更易剥离、分散,进而更好发挥生物驻极体的功效;(2)等离子体处理技术促进了纳米晶须表面活化及在溶液中均分散能力,从而在聚乳酸纳米纤维表面均匀分布,是发挥生物驻极体功能的基础;(3)静电纺丝技术可在含有均分布生物驻极体的聚乳酸纳米纤维中实现极高且长效的表面电位,有助提高纤维膜的过滤效率,具有良好的应用前景。This shows that the technical solution proposed by the present invention enables the biological electret to have good surface properties and structural regularity, as well as the degree of dispersion and efficacy in polylactic acid nanofibers have been significantly improved, which benefits from: (1 ) The structural regularity and uniformity of hydroxyapatite nanowhiskers synthesized by microwave-assisted biomimetic mineralization make it easier to peel and disperse in polylactic acid, thereby better exerting the effect of biological electrets; (2) Plasma treatment The technology promotes the surface activation of nanowhiskers and the ability to disperse them in solution, so that they are evenly distributed on the surface of polylactic acid nanofibers, which is the basis for exerting the function of biological electrets; The extremely high and long-lasting surface potential is achieved in the polar body PLA nanofibers, which helps to improve the filtration efficiency of the fiber membrane and has good application prospects.
Claims (9)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202211024261.8A CN115178105A (en) | 2022-08-25 | 2022-08-25 | Long-acting filtering membrane with uniformly distributed biological electrets on polylactic acid nanofiber surface and preparation method thereof |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202211024261.8A CN115178105A (en) | 2022-08-25 | 2022-08-25 | Long-acting filtering membrane with uniformly distributed biological electrets on polylactic acid nanofiber surface and preparation method thereof |
Publications (1)
Publication Number | Publication Date |
---|---|
CN115178105A true CN115178105A (en) | 2022-10-14 |
Family
ID=83522801
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN202211024261.8A Pending CN115178105A (en) | 2022-08-25 | 2022-08-25 | Long-acting filtering membrane with uniformly distributed biological electrets on polylactic acid nanofiber surface and preparation method thereof |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN115178105A (en) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN117535881A (en) * | 2023-11-20 | 2024-02-09 | 北华航天工业学院 | Bio-based nanowire modified nanofiber membrane and preparation method and application thereof |
Citations (14)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4177228A (en) * | 1977-07-15 | 1979-12-04 | Kilcher-Chemie Ag | Method of production of a micro-porous membrane for filtration plants |
CN101172164A (en) * | 2006-11-03 | 2008-05-07 | 中国科学院化学研究所 | Biodegradable and absorbable biopolymer nanofiber membrane material and its preparation method and application |
CN101507841A (en) * | 2009-03-30 | 2009-08-19 | 西南交通大学 | Preparation method of inorganic calcium phosphate salt/biodegradable polymer fiber film composite material |
CN101791520A (en) * | 2010-04-06 | 2010-08-04 | 东华大学 | Polyether sulfone/hydroxyapatite composite membrane and preparation method and application thereof |
CN105935455A (en) * | 2016-04-18 | 2016-09-14 | 北京林业大学 | Cellulose/hydroxyapatite nano composite material and preparation method thereof |
CN106237717A (en) * | 2016-08-30 | 2016-12-21 | 东华大学 | A kind of efficient low-resistance electrostatic spinning nano fiber air filting material and mass preparation method |
CN106731229A (en) * | 2016-12-30 | 2017-05-31 | 东华大学 | Possesses electret nano-fiber air filter material of water-proof function and preparation method thereof |
CN106853961A (en) * | 2016-12-02 | 2017-06-16 | 中国科学院上海硅酸盐研究所 | Hydroxyapatite nano line, nano wire assembling network structure and preparation method thereof |
CN109019546A (en) * | 2018-08-28 | 2018-12-18 | 深圳市星源材质科技股份有限公司 | The preparation method of hydroxyapatite nano line |
CN110522950A (en) * | 2019-09-26 | 2019-12-03 | 华中科技大学同济医学院附属协和医院 | Silk fibroin/hydroxyapatite composite scaffold and preparation method thereof |
CN110721596A (en) * | 2019-11-22 | 2020-01-24 | 中原工学院 | Preparation method of a novel environmentally friendly and high-efficiency oil-water separation composite membrane |
CN111359452A (en) * | 2020-03-18 | 2020-07-03 | 北京化工大学 | Structure-enhanced hydrotalcite-supported composite fiber membrane, preparation method and application thereof |
CN111472093A (en) * | 2020-04-08 | 2020-07-31 | 武汉理工大学 | Nano-hydroxyapatite/polylactic acid composite fiber membrane and preparation method thereof |
CN113181711A (en) * | 2021-04-26 | 2021-07-30 | 苏州和塑美科技有限公司 | Degradable nanofiber air filtering material and preparation method thereof |
-
2022
- 2022-08-25 CN CN202211024261.8A patent/CN115178105A/en active Pending
Patent Citations (14)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4177228A (en) * | 1977-07-15 | 1979-12-04 | Kilcher-Chemie Ag | Method of production of a micro-porous membrane for filtration plants |
CN101172164A (en) * | 2006-11-03 | 2008-05-07 | 中国科学院化学研究所 | Biodegradable and absorbable biopolymer nanofiber membrane material and its preparation method and application |
CN101507841A (en) * | 2009-03-30 | 2009-08-19 | 西南交通大学 | Preparation method of inorganic calcium phosphate salt/biodegradable polymer fiber film composite material |
CN101791520A (en) * | 2010-04-06 | 2010-08-04 | 东华大学 | Polyether sulfone/hydroxyapatite composite membrane and preparation method and application thereof |
CN105935455A (en) * | 2016-04-18 | 2016-09-14 | 北京林业大学 | Cellulose/hydroxyapatite nano composite material and preparation method thereof |
CN106237717A (en) * | 2016-08-30 | 2016-12-21 | 东华大学 | A kind of efficient low-resistance electrostatic spinning nano fiber air filting material and mass preparation method |
CN106853961A (en) * | 2016-12-02 | 2017-06-16 | 中国科学院上海硅酸盐研究所 | Hydroxyapatite nano line, nano wire assembling network structure and preparation method thereof |
CN106731229A (en) * | 2016-12-30 | 2017-05-31 | 东华大学 | Possesses electret nano-fiber air filter material of water-proof function and preparation method thereof |
CN109019546A (en) * | 2018-08-28 | 2018-12-18 | 深圳市星源材质科技股份有限公司 | The preparation method of hydroxyapatite nano line |
CN110522950A (en) * | 2019-09-26 | 2019-12-03 | 华中科技大学同济医学院附属协和医院 | Silk fibroin/hydroxyapatite composite scaffold and preparation method thereof |
CN110721596A (en) * | 2019-11-22 | 2020-01-24 | 中原工学院 | Preparation method of a novel environmentally friendly and high-efficiency oil-water separation composite membrane |
CN111359452A (en) * | 2020-03-18 | 2020-07-03 | 北京化工大学 | Structure-enhanced hydrotalcite-supported composite fiber membrane, preparation method and application thereof |
CN111472093A (en) * | 2020-04-08 | 2020-07-31 | 武汉理工大学 | Nano-hydroxyapatite/polylactic acid composite fiber membrane and preparation method thereof |
CN113181711A (en) * | 2021-04-26 | 2021-07-30 | 苏州和塑美科技有限公司 | Degradable nanofiber air filtering material and preparation method thereof |
Non-Patent Citations (3)
Title |
---|
KIJENSKA E: "Electrospun bio-composite P(LLA-CL)/collagen I/collagen III scaffolds for nerve tissue engineering", 《 J BIOMED MATER RES BAPPL BIOMATER. 》, vol. 100, no. 04, pages 1093 - 1102 * |
柳志伟: "聚乳酸/羟基磷灰石复合材料微球的制备及表征", 《武汉工程大学学报》, vol. 43, no. 05, pages 525 - 528 * |
毕红艳: "聚乳酸、聚乳酸/纳米羟基磷灰石静电纺丝纤维膜的制备和性能评价", 《中国优秀硕士学位论文全文数据库基础科学辑》, no. 08, pages 14 - 32 * |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN117535881A (en) * | 2023-11-20 | 2024-02-09 | 北华航天工业学院 | Bio-based nanowire modified nanofiber membrane and preparation method and application thereof |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Franco et al. | Electrospun hydroxyapatite fibers from a simple sol–gel system | |
Heydary et al. | Electrospun of polymer/bioceramic nanocomposite as a new soft tissue for biomedical applications | |
Kalra et al. | Confined assembly in coaxially electrospun block copolymer fibers | |
CN108138367B (en) | Nanofiber-nanowire composite and method for producing the same | |
Dadol et al. | Solution blow spinning–polyacrylonitrile–assisted cellulose acetate nanofiber membrane | |
CN103276379A (en) | Method for preparing surface silver-plated electric-spinning fiber by using dopamine | |
CN103173892A (en) | Preparation method of nano bamboo fiber composite material | |
Zhang et al. | High antibacterial performance of electrospinning silk fibroin/gelatin film modified with graphene oxide‐sliver nanoparticles | |
CN103103629A (en) | Fullerene-polymer composite nanofiber and preparation method thereof | |
Zhou et al. | Fabrication and characterization of fibrous HAP/PVP/PEO composites prepared by sol-electrospinning | |
Sebastian et al. | Synthesis of hydroxyapatite fibers using electrospinning: A study of phase evolution based on polymer matrix | |
CN113604964A (en) | Ordered composite fiber membrane and preparation method and application thereof | |
CN115178105A (en) | Long-acting filtering membrane with uniformly distributed biological electrets on polylactic acid nanofiber surface and preparation method thereof | |
CN116905231A (en) | Polylactic acid composite membrane and its preparation method and application | |
CN105816918A (en) | Aliphatic polyester-nano hydroxyapatite composite material and preparation method thereof | |
CN116791233A (en) | Porous polylactic acid antibacterial nanofiber and preparation method thereof | |
CN115161885A (en) | A kind of high filtration efficiency polylactic acid nanofiber membrane containing uniformly dispersed biological electret and preparation method thereof | |
CN108408717B (en) | Preparation method of millimeter-scale porous silicon dioxide/carbon hybrid ball | |
CN105086319A (en) | Bionic-structure hydroxyapatite (Hap)/polymer composite material, and preparation method and application thereof | |
CN104452107A (en) | High-elasticity PHA porous fiber material and preparing method thereof | |
CN114229813A (en) | Strontium hydroxyphosphate overlong nanowire and preparation method and application thereof | |
Christiansen et al. | Solution electrospinning of particle-polymer composite fibres | |
Huang et al. | Preparation of PVA@ PEI@ BAC@ CNC composite nanofibrous film with high efficiency filtration for PM2. 5 | |
Pantasri et al. | Preparation of strontium-and/or zinc-doped hydroxyapatite nanoparticles and their polycaprolactone composite fibrous scaffolds | |
Yuanyuan et al. | Size control of electrospun hydroxyapatite nanofibers by sol–gel system |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination |